Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia

  1. S. Sejil,
  2. B. Janand-Delenne,
  3. J.-F. Avierinos,
  4. G. Habib,
  5. N. Labastie,
  6. D. Raccah,
  7. P. Vague,
  8. V. Lassmann-Vague

Article first published online: 18 SEP 2006

DOI: 10.1111/j.1464-5491.2006.01992.x

Issue

Diabetic Medicine

Diabetic Medicine

Volume 23, Issue 11, pages 1186–1191, November 2006

Additional Information

How to Cite

Sejil, S., Janand-Delenne, B., Avierinos, J.-F., Habib, G., Labastie, N., Raccah, D., Vague, P. and Lassmann-Vague, V. (2006), Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemia. Diabetic Medicine, 23: 1186–1191. doi: 10.1111/j.1464-5491.2006.01992.x

Author Information

  1. Endocrinology–Nutrition–Metabolic Disease Department, Timone University Hospital Centre and *Cardiology Department, Timone University Hospital Centre, Marseille, France

* : Sami Sejil MD, Centre hospitalier du Pays d’Aix, Tamaris Avenue, 13616 Aix en Provence, France. E-mail: ssejil@ch-aix.fr

Publication History

  1. Issue published online: 18 OCT 2006
  2. Article first published online: 18 SEP 2006
  3. Accepted 5 June 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (115K)

Keywords:

  • adult diabetes;
  • cancer;
  • cardiovascular disease;
  • mortality;
  • silent myocardial ischaemia

Abstract

Aims  To determine the prognosis of patients with Type 1 or Type 2 diabetes, 6 years after screening for silent myocardial ischaemia (SMI).

Methods  Two hundred and three asymptomatic patients with diabetes underwent systematic SMI screening. From the results of this screening, they were allocated to one of three groups: patients (n = 171) with negative screening; patients (n = 32) with positive screening; and patients (n = 21) with positive screening and coronary stenosis. Six years after the initial assessment, all patients were re-assessed. All events [death, cardiac death, non-fatal major cardiac events (NFMCEs)—acute myocardial infarction, ventricular rhythm disorders, heart failure, unstable angina] were recorded.

Results  Fifteen patients were lost to follow-up. Patients (n = 20) with positive SMI screening and coronary stenosis had a higher risk of NFMCEs (35% vs. 7%, P < 0.001), and a higher mortality rate (35% vs. 15%, P < 0.05) compared with patients (n = 157) with negative screening. SMI-positive patients (n = 31) had a higher NFMCE rate compared with negative SMI screening patients, although overall mortality rate was no different. Cancer was the leading cause of death (36.4%). In multivariate analysis, major cardiac events (cardiac death and NFMCE) were related to baseline age, body mass index and coronary stenosis (P < 0.01).

Conclusions  Patients with diabetes and SMI have a very poor prognosis as assessed by cardiac events or death, especially in the presence of coronary stenosis.

View Full Article (HTML) Get PDF (115K)